Valisure’s mission is to bring transparency and increased quality to the pharmaceutical industry, and to deliver these benefits throughout the healthcare system. We hope to achieve this through focusing on patient advocacy, consumer protection, and performing advanced research and development.
Founders Adam Clark-Joseph and David Light reconnected after Adam suffered serious complications caused by batch variability of his anticonvulsant medication. Upon further research, they began to grasp the magnitude and pervasiveness of the problem throughout the pharmaceutical industry. Adam and David brought together a team of like-minded scientists and pharmacy experts to develop and deploy a solution. The result was Valisure, a company dedicated to preventing anyone from suffering adverse effects from low quality medications.
Valisure's Leadership Team
See what is being said about Valisure today
Valisure Certified Medications available through a new pharmacy partnership.Learn More
Our pharmacy partner is committed to continuing to provide Valisure Certified medications and exceptional customer service. Any questions please call:833-497-7370
David Light FOUNDER and CEO
David Light, Founder and CEO of Valisure, is a biotech entrepreneur and scientist with over 10 years of broad experience in the field. A graduate of Yale University, David studied molecular biology and has worked in a variety of scientific and business roles at start-ups like Synthetic Genomics, Ion Torrent, and Valisure. At Ion Torrent, David developed key technologies that directly led to the semiconductor DNA sequencing company's $725M acquisition and ran its flagship technology programs through development and global commercialization. David helped found, fund, and invent the core technology at Valisure. David is named inventor on numerous patents, published in journals including Nature and the cover of Electrophoresis, has been invited to submit testimony at congressional hearings as well as speak at the U.S. Capitol Building on the introduction of critical bills regarding medication safety and quality.
Kaury Kucera, PhD Chief Scientific Officer
Dr. Kaury Kucera is Valisure’s Chief Scientific Officer, where she oversees all lab activities including medication testing and test design. She is a pharmaceutical biochemist with degrees in molecular biophysics and biochemistry from the University of Chicago and Yale University. Her studies included natural product medicinal chemistry in the Department of Molecular Biophysics and Biochemistry at Yale University and structure-based drug development and screening in the Department of Pharmacology at Yale University. Prior to joining Valisure, Dr. Kucera led a large-scale and multi-year effort by Yale University aimed at discovering new organic compounds from the Amazon rain forest; in that context, Dr. Kucera oversaw the development of hundreds of unique assays.
Dr. Qian Wu Director of Mass Spectrometry
Dr. Qian Wu is Valisure's Director for Mass Spectrometry, where he oversees routine and research-based testing of impurities, including carcinogens, in pharmaceutical samples using mass spectrometry technology. Qian has a passion in developing and executing high-quality analytical methods with an implication to resolve real-world public health problems. Prior to joining Valisure, Qian was a research scientist at the Wadsworth Center, New York State Department of Health, and led the laboratory effort in investigations of perfluoroalkyl substances (PFAS) contamination in public drinking water and their human exposure, which assisted New York State to set the most stringent drinking water PFAS standards in the nation. Qian earned his Ph.D. in Environmental Health Sciences from the School of Public Health, State University of New York at Albany, and has published over 50 peer-reviewed articles to date.
Adam Clark-Joseph, PhD FOUNDER
Adam is an assistant professor of finance at the University of Illinois at Urbana-Champaign. He holds a PhD in economics from Harvard, a master’s degree from Cambridge, and bachelor’s degrees in math and economics from Yale. Adam was the recipient of a NSF Graduate Research Fellowship and a Gates Cambridge Scholarship. His academic research focuses on algorithmic trading, and empirical applications of high-performance computing and novel statistical methods.
Robert Cunningham FOUNDER and Chief Business Officer
Bob is responsible for Valisure’s corporate alliances and strategic planning activities. He is the past Director of Platform Development at the Wyss Institute at Harvard University, where he was responsible for the implementation of commercialization and technology translation strategies. His industry experience with Haemonetics, endoVia Medical, RainDance Technologies, and Hemocell includes founder, CEO and other executive roles in companies commercializing innovative technologies. He holds a degree in Biochemistry from the University of California at San Diego and is a member of the Massachusetts Biotechnology Industry Council.
Wolfgang Hinz, PhD FOUNDER
Dr. Wolfgang Hinz is a medicinal chemist and is a Senior Director in the Clinical Sequencing Division of Thermo Fisher Scientific. At Valisure, Dr. Hinz focuses on ongoing technology development and implementation. Dr. Hinz completed his bachelor's and graduate training at the University of Cape Town as well as postdoctoral fellowships at Yale University and Yale School of Medicine in Physical Organic Chemistry and Pharmacology. Dr. Hinz was previously the Senior Research Scientist at the Rothberg Institute for Childhood Diseases and Raindance Technologies. Dr. Hinz is passionate about the use of technology to solve problems in public health, and is the named inventor on 86 granted U.S. patents and an additional 144 U.S. patent applications.
Alexandra Jirstrand Chief Communications Officer Government Affairs
Alexandra Jirstrand, Chief Communications Officer and Government Affairs at Valisure, is a communications and public relations executive with more than 20 years of strategy, corporate communications, and media relations experience. Prior to joining Valisure, Alexandra was a vice president of the consumer division at Rubenstein Public Relations. At Edelman Public Relations, Alexandra was the vice president responsible for the global branding, public relations, and social mission for Dove and Unilever. She led the team that created the 10th Anniversary of Dove’s groundbreaking Campaign for Real Beauty. Alexandra conceived Dove’s documentary short-film Selfie, which premiered at the 2014 Sundance Film Festival; the film won a Clio Award and was nominated for a Cannes Lion Award. Alexandra has worked for healthcare non-profit organizations including The National Council for Behavioral Health and the Robert Wood Johnson Foundation, and on consumer brands including Martha Stewart Living Omnimedia, Bloomingdale’s and HINT Water. She graduated Fairleigh Dickinson University with a BA in English Literature and art history with a minor in media studies.